Evaluation of the Effect of Changyou Probiotic Flavored Yogurt on Intestinal Health
NCT ID: NCT04375475
Last Updated: 2020-05-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
198 participants
INTERVENTIONAL
2019-02-25
2019-04-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The objectives of this study were to evaluate the effect of the Bright Changyou Probiotic Flavored Yogurt on:
Improving gastrointestinal health; Relieving symptoms of functional constipation or functional diarrhea; Improving gut immunity; Adjusting microbiological flora in gastrointestinal tract.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Yili "Changqing" Pro-ABB Yoghurt in the Improvement of Human Gastrointestinal Tract System
NCT01682798
Immune System Stimulation by Probiotic Food Supplementation
NCT03049579
Effects of Fermented Dairy Products on Defecation Changes Through Gut Microbiota
NCT06862310
Exploring the Potential Benefits of Probiotic Yogurt
NCT06847919
Physiological Effects of Yogurt With Bb12 in Subjects With GI Symptoms Strointestinal Symptoms
NCT01004484
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bright Changyou probiotic flavored yogurt
Bright Changyou probiotic flavored yogurt contains 5.0×10\^8cfu/g of probiotics including Lactobacillus bulgaricus, Streptococcus thermophilus, Bifidobacterium lactis, Lactobacillus acidophilus, Lactobacillus plantarum ST-Ⅲ (7mg/kg), and 1.5% of inulin
Bright Changyou probiotic flavored yogurt
Oral consumption of Bright Changyou probiotic flavored yogurt 100 g at a time and twice per day for 28 days. The experimental product has similar package and taste as the comparators.
Bright Changyou lactobacillus flavored yogurt
Bright Changyou flavored yogurt contains probiotics including Lactobacillus bulgaricus, Streptococcus thermophilus, Bifidobacterium lactis, Lactobacillus acidophilus, and Lactobacillus plantarum ST-Ⅲ (7mg/kg)
Bright Changyou lactobacillus flavored yogurt
Oral consumption of Bright Changyou lactobacillus flavored yogurt 100 g at a time and twice per day for 28 days.
Bright flavored yogurt
Bright flavored yogurt contains Lactobacillus bulgaricus, Streptococcus thermophilus, Lactobacillus acidophilus, Bifidobacterium lactis, and Lactobacillus casei LC2W (0.1 mg/kg)
Bright flavored yogurt
Oral consumption of Bright flavored yogurt 100 g at a time and twice per day for 28 days.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bright Changyou probiotic flavored yogurt
Oral consumption of Bright Changyou probiotic flavored yogurt 100 g at a time and twice per day for 28 days. The experimental product has similar package and taste as the comparators.
Bright Changyou lactobacillus flavored yogurt
Oral consumption of Bright Changyou lactobacillus flavored yogurt 100 g at a time and twice per day for 28 days.
Bright flavored yogurt
Oral consumption of Bright flavored yogurt 100 g at a time and twice per day for 28 days.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Functional constipation or diarrhea diagnosed by Rome III criteria;
* Agree not to take any dietary supplements or dairy products other than the study products during the study period;
* Agree not to take any supplements or dairy products containing prebiotics/probiotics other than the study products during the study period;
* Agree not to participant in other interventional studies during the study period;
* Fully understand the property, purpose, benefits and potential risk and side effect from the study;
* Agree to follow all study requirements and procedures;
* Signed informed consent.
Exclusion Criteria
* Lactose intolerance;
* Having diseases or conditions that may affect intestinal function, such as history of gastrointestinal resection, colon or rectal cancer, inflammatory bowel disease, diabetes, hyperthyroidism or hypothyroidism, Hirschsprung's disease, scleroderma, or Anorexia nervosa;
* Currently under diet control or in use of medicine or supplements for weight control or that might affect appetite;
* Have had laxatives or other substance that will enhance digestion within two weeks before the study begins;
* Have had dairy products or other food containing probiotics within 10 days before the study begins;
* Currently having diarrhea;
* Currently pregnant or breast-feeding, or plan to be pregnant during the study period;
* Not be able to follow study procedures according to investigators evaluation.
25 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bright Dairy & Food Co., Ltd
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shanghai Jiaoton University Affiliated Xinhua Hospital
Shanghai, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
19-SM-02-GM-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.